SNN — SMITH & NEPHEW SNATS INC (Healthcare >> Medical Devices)
SNN FAQ
What is SNN's P/E ratio?
SMITH & NEPHEW SNATS INC (SNN) currently trades at a P/E ratio of 12.87.
What is SNN's ROE?
SMITH & NEPHEW SNATS INC reports a Return on Equity (ROE) of 11.84%.
What is SNN's dividend yield?
SMITH & NEPHEW SNATS INC offers a dividend yield of 2.53%.
What is SNN's Deepscope Quality Score?
Deepscope rates SNN's overall financial quality at 62 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy SNN?
Deepscope's AI Timing Score for SNN is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does SNN belong to?
SMITH & NEPHEW SNATS INC is classified under the Healthcare >> Medical Devices sector on the NYSE exchange.
|
USD 30.61
Price
-0.24
(-0.78%)
Day Change
|
|
|---|
SNN, the overall quality is ok ( Quality = 62) and the timing to buy is ...(Sign In to See)...
- Signal
- NEUTRAL
- Signal Description
- Company financial health is OK
- Reason
-
ROE is relatively low.
Historical ROE is relatively low
ROA is too relatively low compare to ROE
Net profit margin is relatively low.
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not quite good , financial health is not quite good , and ability to make profit is ok , ...
| Quality Factors |
|
55% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 81 |
| Magic Formula Rank by ROA |
1226
|
| Magic Formula Rank by ROE |
1226
|
| Magic Formula Rank by ROIC |
1069
|
| Price | 30.61 |
| PBV / Sector |
2.53 / 7.50
|
| Earning Per Share | 1.44 |
| PE / Sector |
12.87 / 29.01
GOOD
|
| PEG or PE/Growth / Sector |
0.23 / 0.39
GREAT
|
| Average 1M Daily Value |
35.14 M
GREAT
|
| Average 1W Daily Value |
43.63 M
GREAT
|
| Timing Factors |
|
57% |
| Financial Health |
|
50% |
| Ability to Make Profit |
|
60% |
| Return to Investors |
|
12% |
| Registration Details |
| Analyze Date | 2026-06-06 09:09:11 |
| Symbol | SNN |
| Name | SMITH & NEPHEW SNATS INC |
| Sector | Healthcare >> Medical Devices |
| Market | NYSE |
| Listed Shares | 424.90 M |
| Par Value | N/A |
| Calculated From | YearEnd |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 13,360.25 / 18,389.26 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: Building 5, Watford, United Kingdom, WD18 8YE
Phone: 44 1923 477 100
Website: https://www.smith-nephew.com
Employees: 16,988
Sector: Healthcare >> Medical Devices
Description: Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. The company also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, it provides arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, the company offers advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
Google